NO953673D0 - [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse - Google Patents

[1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse

Info

Publication number
NO953673D0
NO953673D0 NO953673A NO953673A NO953673D0 NO 953673 D0 NO953673 D0 NO 953673D0 NO 953673 A NO953673 A NO 953673A NO 953673 A NO953673 A NO 953673A NO 953673 D0 NO953673 D0 NO 953673D0
Authority
NO
Norway
Prior art keywords
aquinoxaline
derivatives
preparation
aquinoxaline derivatives
Prior art date
Application number
NO953673A
Other languages
English (en)
Other versions
NO305286B1 (no
NO953673L (no
Inventor
Poul Jacobsen
Flemming Elmelund Nielsen
Lone Jeppesen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO953673D0 publication Critical patent/NO953673D0/no
Publication of NO953673L publication Critical patent/NO953673L/no
Publication of NO305286B1 publication Critical patent/NO305286B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO953673A 1993-03-19 1995-09-18 Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter NO305286B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93310A DK31093D0 (no) 1993-03-19 1993-03-19
PCT/DK1994/000077 WO1994021639A1 (en) 1993-03-19 1994-02-25 [1,2,4] TRIAZOLO [4,3-a] QUINOXALINE DERIVATIVES, THEIR PREPARATION AND USE

Publications (3)

Publication Number Publication Date
NO953673D0 true NO953673D0 (no) 1995-09-18
NO953673L NO953673L (no) 1995-11-17
NO305286B1 NO305286B1 (no) 1999-05-03

Family

ID=8092112

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953673A NO305286B1 (no) 1993-03-19 1995-09-18 Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter

Country Status (16)

Country Link
US (1) US5559106A (no)
EP (1) EP0691969A1 (no)
JP (1) JPH08507536A (no)
KR (1) KR100313051B1 (no)
CN (1) CN1041930C (no)
AU (1) AU685783B2 (no)
CA (1) CA2158545A1 (no)
DK (1) DK31093D0 (no)
FI (1) FI954386A7 (no)
HU (1) HUT73419A (no)
IL (1) IL108800A (no)
NO (1) NO305286B1 (no)
NZ (1) NZ262365A (no)
TW (1) TW304195B (no)
WO (1) WO1994021639A1 (no)
ZA (1) ZA941926B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4314592A1 (de) * 1993-04-28 1994-11-03 Schering Ag Benzo(f)chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
AU694554B2 (en) * 1994-09-16 1998-07-23 Novo Nordisk A/S {1,2,4}triazolo{4,3-a}quinoxalinone derivatives, their preparation and use
CZ285248B6 (cs) * 1994-09-16 1999-06-16 Novo Nordisk A/S [1,2,4]triazolo[4,3-a]chinoxalinonové deriváty, jejich příprava a použití
US5679680A (en) * 1995-02-16 1997-10-21 Warner-Lambert Company α-substituted hydrazides having calpain inhibitory activity
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
IL125950A0 (en) * 1997-09-05 1999-04-11 Pfizer Prod Inc Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
EP1050535A4 (en) 1997-11-11 2001-04-25 Ono Pharmaceutical Co CONDENSED PYRAZINE DERIVATIVES
AU2298399A (en) * 1998-02-06 1999-08-23 Yoshitomi Pharmaceutical Industries, Ltd. Novel azapeptide type hydroxamic acid derivatives
US20040152694A1 (en) * 2003-02-04 2004-08-05 Istvan Kurucz Methods and compositions for treating inflammatory disorders of the airways
US8299080B2 (en) * 2006-12-13 2012-10-30 Aska Pharmaceutical Co., Ltd. Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor
CN102341399A (zh) 2009-03-05 2012-02-01 安斯泰来制药株式会社 喹喔啉化合物
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
PT2615096T (pt) * 2010-09-07 2019-10-15 Astellas Pharma Inc Composto de quinoxalina
BR112013033375B1 (pt) * 2011-06-27 2022-05-10 Janssen Pharmaceutica N.V Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxa-lina, seu uso, composição farmacêutica que os compreende, processo de preparação dos mesmos, solução estéril e composto intermediário
RU2657540C2 (ru) 2012-06-26 2018-06-14 Янссен Фармацевтика Нв Комбинации, содержащие ингибиторы pde 2, такие как 1-арил-4-метил-[1,2,4]триазоло[4,3-а]хиноксалиновые соединения, и ингибиторы pde 10, для применения в лечении неврологических или метаболических расстройств

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4354027A (en) * 1980-05-19 1982-10-12 Usv Pharmaceutical Corporation Triazoloquinoxalin-4-ones
US4547501A (en) * 1983-09-02 1985-10-15 Pfizer Inc. Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
AU3767793A (en) * 1992-04-03 1993-11-08 Yamanouchi Pharmaceutical Co., Ltd. Fused quinoxalinone derivative and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
TW304195B (no) 1997-05-01
HU9502726D0 (en) 1995-11-28
CN1122601A (zh) 1996-05-15
NZ262365A (en) 1997-05-26
ZA941926B (en) 1995-09-18
FI954386A0 (fi) 1995-09-18
FI954386L (fi) 1995-09-18
HUT73419A (en) 1996-07-29
US5559106A (en) 1996-09-24
DK31093D0 (no) 1993-03-19
EP0691969A1 (en) 1996-01-17
IL108800A (en) 1998-02-22
CN1041930C (zh) 1999-02-03
AU685783B2 (en) 1998-01-29
KR100313051B1 (ko) 2002-02-28
KR960701057A (ko) 1996-02-24
WO1994021639A1 (en) 1994-09-29
FI954386A7 (fi) 1995-09-18
CA2158545A1 (en) 1994-09-29
JPH08507536A (ja) 1996-08-13
NO305286B1 (no) 1999-05-03
AU6201894A (en) 1994-10-11
IL108800A0 (en) 1994-06-24
NO953673L (no) 1995-11-17

Similar Documents

Publication Publication Date Title
NO933434D0 (no) Piperidinderivater, deres fremstilling og anvendelse
NO954369D0 (no) Oksazolidindionderivater, deres fremstilling og anvendelse
DK374389A (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
DK609489A (da) Imidazolderivater, deres fremstilling og anvendelse
DK1019358T4 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
DK0871656T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO953673L (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
DK388989D0 (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
DK435289D0 (da) Piperazindioner, deres fremstilling og anvendelse
DK473289A (da) 2'-halogenmethyliden-, 2'-ethenyliden- og 2'-ethynyl-adenosin-derivater, deres fremstilling og anvendelse
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
NO954763D0 (no) Piperidinderivater, deres fremstilling og anvendelse
NO933435D0 (no) Piperidinderivater, deres fremstilling og anvendelse
DK73091D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DK225089A (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
DK469389D0 (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
NO179073C (no) Imid-terminerte polynitrogenforbindelser, deres fremstilling og anvendelse
DK592389D0 (da) Penemderivater, deres fremstilling og anvendelse
NO951812D0 (no) Pyrrolderivater, deres fremstilling og anvendelse
FI955680A7 (fi) Psoraleenijohdannaiset, niiden valmistus ja käyttö
DK455189D0 (da) 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse
NO920228D0 (no) Polylaktider, deres fremstilling og anvendelse
NO923042D0 (no) 4,5-cykloalkano-3-benzazepin-7-ol-derivater og deres anvendelse
DK30693D0 (da) Heterocycliske forbindelser, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees